Novel small molecule inhibitor of C1s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits

Journal of Immunology

Volumn 167, Issue 9, 2001, Pages 5375-5380

  Buerke, M ^a   Schwertz, H ^a   Seitz, W ^a   Meyer, J ^a   Darius, H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; CREATINE KINASE; MYELOPEROXIDASE; OXYGEN RADICAL;

ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE RELEASE; DOSE RESPONSE; DRUG POTENCY; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REPERFUSION INJURY;

EID: 0035500616     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.9.5375     Document Type: Article

References (37)

1. Myocardial infarct extension during reperfusion after coronary artery occlusion: Pathologic evidence
2. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion
3. Inflammation in the course of early myocardial ischemia
4. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
5. Ischemia-reperfusion-injury
6. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion
7. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion
8. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury
9. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart: Evidence that complement activation is required for neutrophil-mediated reperfusion injury
10. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
11. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: Role of the terminal complement components and inhibition by anti-C5 therapy
12. C1-esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema
13. Isolation of human complement subcomponents C1r and Cls in their unactivated, proenzyme forms
14. 2+ -independent association with a C1s-like serine protease
15. Determination of serum protein by means of the biuret method
16. An improved procedure for serum creatine phosphokinase determination
17. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
18. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium
19. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle
20. A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies
21. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs
22. Recombinant human complement C5a receptor antagonist reduces infarct size following surgical revascularization
23. C1 inhibitor in anti-inflammatory therapy: From animal experiment to clinical application
24. Tissue destruction by neutrophils
25. Cleavage and inactivation of human C1 inhibitor by the human leukocyte proteinase, proteinase 3
26. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle: A possible initiator of an extra myocardial mechanism of ischemic injury
27. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium
28. Early accumulation of the terminal complement complex in the ischaemic myocardium after reperfusion
29. Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: A comparison between C6-competent and C6-deficient rabbits
30. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs
31. Role of selectins, a new family of adhesion molecules, in ischaemia- reperfusion injury
32. Selectins
33. 5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface
34. C5a-induced expression of P-selectin in endothelial cells
35. Humanized monoclonal antibody DREG-200 directed against 1-selectin protects in feline myocardial reperfusion injury
36. Sialyl Lewis??-containing oligosaccharide attenuates myocardial reperfusion injury in cats
37. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM- 1